Journal of Minimally Invasive Surgery 2019; 22(2): 69-74
Published online June 15, 2019
https://doi.org/10.7602/jmis.2019.22.2.69
© The Korean Society of Endo-Laparoscopic & Robotic Surgery
Correspondence to : Sang Kuon Lee, Department of Surgery, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 64 Daeheung-ro, Jung-gu, Daejeon 34943, Korea, Tel: +82-42-220-9520, Fax: +82-42-220-9565, E-mail: luislee@catholic.ac.kr, ORCID:
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
The critical pathway (CP) was introduced as a means to provide quality healthcare service in many fields of surgery. CP may increase the patient’s satisfaction rate and lowering hospital stay and medical cost also. We aimed to compare the two kinds of CP applied in laparoscopic cholecystectomy patients by different hospital stay length. From March 2016 to October 2016, 71 patients were enrolled in this analysis among 241 patients who underwent elective laparoscopic cholecystectomy. Patients were divided into two groups, 38 patients in the 1-day CP group and 33 patients in the 2-day CP group. In a retrospective review, surgical outcomes and related hospital costs were analyzed. Preoperative characteristics were not different between two CP groups. In analysis of operative outcome, 2-day CP group showed longer operative time than 1-day CP (73.4 vs 54.1 min, The length of hospital stay was shortened in 1-day CP group than in 2-day CP group, while there was no difference in other parameters. Therefore, it is feasible and safe practical policy the use 1-day CP in selected patients who undergo cholecystectomy according to our results.Purpose
Methods
Results
Conclusion
Keywords Cholecystectomy, Laparoscopic, Critical pathways, Hospital costs
Laparoscopic cholecystectomy is the most effective treatment for patients with symptomatic gallbladder diseases.1–3 Laparoscopic cholecystectomy has been widely used because it is associated with shorter hospital stay, shorter recovery period, lower hospital cost, and postoperative pain reduction. Open cholecystectomy has been limited to acute cholecystitis with complications.4 In recent years, in many hospitals, laparoscopic cholecystectomy has been performed under a systematic treatment algorithm using the critical pathway (CP), which is a series of standardized processes for the diagnosis or treatment of a defined condition based on practice guidelines in order to improve outcomes and reduce costs.3,5–7 Laparoscopic cholecystectomy using CP is based on the concept of rapid recovery after surgery (Enhanced Recovery After Surgery (ERAS)).8 ERAS is a basic concept that helps patients to recover faster after surgery by minimizing the physical effects on the human body and reducing the stress response.9
It has been proved in other studies that it is possible to effectively reduce the hospital stay and the cost of hospitalization when CP is applied. Furthermore, some studies revealed that there was no significant difference in the re-admission rate, visual analogue scale (VAS) pain score, and postoperative complication rate comparing day-surgery and overnight stay surgery in laparoscopic cholecystectomy. However, it was difficult to find studies that directly compare two CPs with different hospital stay period.
The purpose of this study was to evaluate the usefulness of standard guideline for laparoscopic cholecystectomy in terms of length of stay and cost. In this study, we tried to find out whether there is significant difference between 1-day CP (discharge from hospital on postoperative day 1) and 2-day CP (discharge from hospital on postoperative day 2) focused on medical and socioeconomic viewpoints.
This retrospective study was approved by the Institutional Review Boards of the institution (DC16RISI0049). At the department of General Surgery of Daejeon St. Mary’s hospital, two types of CP of laparoscopic cholecystectomy were developed and applied to patients by surgeon’s decision: 1-day CP and 2-day CP. Though there are not different statistically, there was a tendency that patients with multiple comorbidities and history of previous abdominal surgery was preferentially included in the 2-day CP group.
Inclusion and exclusion criteria for CP was summarized in Table 1.
One- and 2-day CPs had the same preoperative and postoperative orders. Lists of IV and PO medications were the same between two CPs.
All patients admitted via outpatient clinic and received elective laparoscopic cholecystectomy. The operation proceeded according to conventional laparoscopic cholecystectomy. The number of laparoscopic ports ranged from single port to 3 ports. The choice of port number determined by various factors such as preference of patient, patient’s age and BMI, history of previous surgery, severity of comorbidities, among others.
Patients visited outpatient department 1 week after the discharge day and complete blood cell count and liver function follow up tests were obtained. After 1 month from the first follow up visit, a second outpatient follow up visit was done. Final postoperative complications data was analyzed including medical records of outpatient clinic.
Numerical Rating Scale (NRS) pain scores were checked during the admission at 8-hour intervals and the number of injection of analgesics was counted.
Total admission cost and actual patient’s expenditures were also analyzed. The actual expenditure of the patient was calculated as the total medical expenses minus the national health insurance payments.
Statistical analysis was done by SPSS version 22 (IBM: Armonk, NY, USA). Heterogeneity of characteristics of two groups was determined by Pearson-x2 test (in case of comparison of proportion) and Student t-test (in case of comparison of continuous variables) with significance set at
From March 2016 to October 2016, among 241 patients who underwent elective laparoscopic cholecystectomy.
With exclusion of 170 patients, finally 71 were enrolled and analyzed. Selected patients were admitted through outpatient department and 1-day CP or 2-day CP was applied, based on patient’s characteristics. Patients were divided into two groups for analysis, 38 patients in the 1-day CP group and 33 patients in the 2-day CP group.
Among 170 excluded patients, 124 were not eligible for CP. Most common reasons for ineligibility were complicated cholecystitis (32 cases) such as gallbladder empyema or perforation. Twenty-seven patients with ASA (American Society of Anesthesiologists) classification of 3 or more were excluded. Nineteen patients had previous upper abdominal operation history and 11 concomitant common bile duct stone. Finally, 35 patients did not agree to be enrolled in CP.
Forty-six patients were dropped out during admission. The most common reason was refusal to be discharged (25 cases) followed by abnormal laboratory results (7 cases), earlier discharge (6 cases), need to get financial support (5 cases), change of operation schedule (1 case), and unexpected concomitant common bile duct stone (1 case). One patient was lost during follow up (Fig. 1).
Pre-operative characteristics of 2-day CP and 1-day CP groups are shown in Table 2. Among the list, there was no statistically significant difference between two groups in age (52 vs 49 years old,
Operative outcomes were summarized in Table 3. Two-day CP group showed longer operative time than 1-day CP group (73.4 vs 54.1 min,
Recently, the application of critical pathway to laparoscopic cholecystectomy has been steadily increasing because it is associated with shorter hospital stay, reduced hospital costs and increased availability of hospital bed capacity.3,10,11
However, there are still some studies reporting unrecognized complications during laparoscopic cholecystectomy, especially in elderly patients with multiple comorbidities.12,13 It is a reasonable concern laparoscopic cholecystectomy using critical pathway may neglect some of the later complications because of forced earlier hospital discharge. Furthermore, complications such as bile duct injury, hemobilia and bowel injury could be life-threatening unless timely detected and properly treated. This is the reason why the critical pathway could not be applied collectively to all patients. In this study, among 241 elective cholecystectomy patients critical pathway was applied to only 117 patients (48.5%). Our critical pathway inclusion rate is lower than other reports because we were more conservative in including patients to critical pathway.
During hospitalization, 46 cases of drop-out were found, however, there was no case of drop-out related to postoperative complications, and none had different treatment or intervention during admission. Most of the drop-out cases were refusal to be discharged complaining postoperative abdominal pain or discomfort. All of them were discharged after one or two more days of admission without different treatment than usual.
There was significant difference in terms of operative time between 1-day and 2-day CP groups. Since the decision to include either in 1-day or 2-day group was taken by the surgeon’s preference or at the patients’ request, selection bias was inevitable. Although not statistically significant, preoperative characteristics (Table 2) showed patients with multiple comorbidities and history of previous abdominal surgery was preferentially included in the 2-day CP group, this factor also may have affected in operative time.
Except for two superficial surgical site infections, there was only one actual postoperative complication in this study. A patient who completed 2-day CP, returned to hospital to outpatient clinic six days after discharge with fever and chilling sensation. Multiple sub centimeter-sized multiple liver abscesses were found on abdominal CT scan. Since this patient had preoperative history of common bile duct stone removal via ERCP, we presumed that subclinical cholangitis existed preoperatively, which developed into multiple small liver abscesses. He was readmitted and properly treated with IV antibiotics and discharged uneventfully on seventh hospital day.
We could not identify statistically significant difference of medical cost between 1-day and 2-day CP groups in this study. However, 1-day CP group showed lower mean and median value of medical cost than 2-day CP group as to both total hospital costs and patients’ expenditures.
Recently, same-day discharge CP after laparoscopic cholecystectomy has been adopted in some hospitals. Henri et al.14 found that careful patient selection, patient education, and experienced surgical team were needed for successful outpatient laparoscopic cholecystectomy utilizing critical pathway. Thomas et al.15 reported that outpatient laparoscopic cholecystectomy with critical pathway was not successful in terms of postoperative recovery in patients older than 50 years, ASA score of 3 or more, and those operated after 1 pm. Discharge plan scheduled in critical pathway was delayed in those patients group.
We did not apply same-day discharge CP of laparoscopic cholecystectomy in our hospital, because we were not sure about the benefits of this kind of patient management strategy and also, there is no firm conclusion whether same-day discharge is safe or not. Beside, our patient population is generally reticent about being discharged on the same day of surgery. Also, in surgical innovation, we thought that conservative step-by-step adaptation is an important policy.
In this study, we did not impose limitation on patients’ age or scheduled operation time for CP enrollment. Actually, oldest patient who underwent laparoscopic cholecystectomy with CP was 81 years old and completed 1-day CP without any complications and there was no case of drop out from CP for afternoon operation schedule. Based on this study, we thought further study about feasibility and safety of outpatient laparoscopic cholecystectomy with CP in selected patients is possible.
In conclusion, though this study has a limitation of being a retrospective review with possible selection bias, it is not only feasible and safe, but also practical the application of 1-day CP for selected patients who undergo laparoscopic cholecystectomy. Our message is 1-day CP application is not inferior to 2-day CP and we hope this study would be helpful for surgeons who wishes to reduce postoperative hospital stay after laparoscopic cholecystectomies.
Nevertheless, larger prospective randomized comparative trials are necessary to confirm our affirmations and draw definitive conclusions.
None.
None.
None.
Inclusion and exclusion criteria for laparoscopic cholecystectomy CP
Inclusion criteria | Exclusion criteria |
---|---|
Gallbladder stone, gallbladder polyp | Cholecystitis with complications (empyema, perforation) |
Admitted via out-patient department | Accompanied CBD stone |
Agreed with critical pathway | Emergency operation |
ASA classification of 3 or more | |
Open conversion | |
Operative complication; biliary tract injury | |
Refused to be discharged as scheduled | |
Disagreed with critical pathway |
ASA = American Society of Anesthesiologists; CBD = common bile duct.
Patients’ preoperative characteristics comparing 2-day CP and 1-day CP
All population (N=71) | 2-day CP (N=33) | 1-day CP (N=38) | ||
---|---|---|---|---|
Age (years) | 0.472 | |||
Mean (SD) | 50 (14) | 52 (13) | 49 (15) | |
Median (range) | 48 (24~81) | 50 (31~78) | 46 (24~81) | |
Gender, N (%) | 0.295 | |||
Male | 37 (52.1) | 15 (45.5) | 22 (57.9) | |
Female | 34 (47.9) | 18 (55.5) | 16 (42.1) | |
Comorbidity*, N (%) | 0.127 | |||
Multiple comorbidities | 9 (12.7) | 7 (21.2) | 2 (5.3) | |
One comorbidity | 25 (35.2) | 10 (30.3) | 15 (39.5) | |
None | 37 (52.1) | 16 (48.5) | 21 (55.3) | |
Abdominal surgery, N (%) | 0.373 | |||
Yes | 16 (22.5) | 9 (27.3) | 7 (18.4) | |
No | 55 (77.5) | 24 (72.7) | 31 (81.6) | |
Pre-op ERCP, N (%) | 0.810 | |||
Yes | 10 (14.1) | 5 (15.2) | 5 (13.2) | |
No | 61 (85.9) | 28 (84.8) | 33 (86.8) | |
Diagnosis (pathologic), N (%) | 0.757 | |||
Cholecystitis without stone | 22 (31.0) | 9 (27.3) | 13 (34.2) | |
Cholecystitis with stone | 36 (50.7) | 18 (54.5) | 18 (47.4) | |
Gallbladder polyp | 8 (11.3) | 3 (9.1) | 5 (13.2) | |
Porcelain gallbladder | 1 (1.4) | 1 (3.0) | 0 (0.0) | |
Xanthogranulomatosis | 4 (5.6) | 2 (6.1) | 2 (5.3) |
CP = critical pathway; SD = standard deviation; ERCP = endoscopic retrograde cholangiopancreatography.
Including diabetes mellitus, hypertension, cerebrovascular accident, angina and systemic diseases regarded in ASA classification.
Comparison of operative outcomes of 2-day CP and 1-day CP
All population (N=71) | 2-day CP (N=33) | 1-day CP (N=38) | ||
---|---|---|---|---|
Port number, N (%) | 0.084 | |||
Single port | 31 (43.7) | 18 (54.6) | 13 (34.2) | |
Multiport | 40 (56.3) | 15 (45.4) | 25 (65.8) | |
Operation time (min) | <0.001 | |||
Mean (SD) | 63.1 (23.5) | 73.4 (24.7) | 54.1 (18.4) | |
Median (range) | 59 (25~125) | 70 (40~125) | 53 (25~96) | |
Complication, N (%) | 0.474 | |||
Yes | 3 (4.2) | 2 (6.1) | 1 (2.6) | |
No | 68 (95.8) | 31 (93.9) | 37 (97.4) | |
Pain scale, NRS | 0.052 | |||
Mean (SD) | 2.00 (0.74) | 1.82 (0.64) | 2.16 (0.79) | |
Median (range) | 2 (0~3) | 2 (0~3) | 2 (0~3) | |
Count of analgesics injection, N | 0.754 | |||
Mean (SD) | 0.14 (0.49) | 0.12 (0.42) | 0.16 (0.55) | |
Median (range) | 0 (0~3) | 0 (0~2) | 0 (0~3) | |
Outpatient follow-up laboratory values, Mean (SD) | ||||
WBC (/mm3) | 6617 (1458) | 6494 (1537) | 6724 (1397) | 0.512 |
Hemoglobin (g/dl) | 13.6 (1.2) | 13.5 (1.1) | 13.7 (1.4) | 0.604 |
Total bilirubin (mg/dl) | 0.54 (0.32) | 0.54 (0.41) | 0.54 (0.24) | 0.995 |
AST (IU/L) | 20.0 (9.2) | 18.3 (5.4) | 21.5 (11.4) | 0.137 |
ALT (IU/L) | 24.9 (20.5) | 21.8 (12.4) | 27.7 (25.4) | 0.208 |
Total admission cost, ×104 won | 0.106 | |||
Mean (SD) | 331.51 (34.23) | 347.04 (25.95) | 306.69 (29.80) | |
Median (range) | 328.39 (267.85~398.47) | 343.95 (281.55~398.47) | 296.38 (267.85~385.00) | |
Actual patient’s expenditure, ×104 won | 0.276 | |||
Mean (SD) | 138.03 (24.82) | 147.85 (20.67) | 125.58 (27.97) | |
Median (range) | 137.04 (77.47~179.66) | 150.74 (89.86~189.66) | 122.66 (77.47~185.64) |
Journal of Minimally Invasive Surgery 2019; 22(2): 69-74
Published online June 15, 2019 https://doi.org/10.7602/jmis.2019.22.2.69
Copyright © The Korean Society of Endo-Laparoscopic & Robotic Surgery.
Jae Woo Park, Munjin Kim, Sang Kuon Lee
Department of Surgery, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea
Correspondence to:Sang Kuon Lee, Department of Surgery, Daejeon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 64 Daeheung-ro, Jung-gu, Daejeon 34943, Korea, Tel: +82-42-220-9520, Fax: +82-42-220-9565, E-mail: luislee@catholic.ac.kr, ORCID:
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
The critical pathway (CP) was introduced as a means to provide quality healthcare service in many fields of surgery. CP may increase the patient’s satisfaction rate and lowering hospital stay and medical cost also. We aimed to compare the two kinds of CP applied in laparoscopic cholecystectomy patients by different hospital stay length. From March 2016 to October 2016, 71 patients were enrolled in this analysis among 241 patients who underwent elective laparoscopic cholecystectomy. Patients were divided into two groups, 38 patients in the 1-day CP group and 33 patients in the 2-day CP group. In a retrospective review, surgical outcomes and related hospital costs were analyzed. Preoperative characteristics were not different between two CP groups. In analysis of operative outcome, 2-day CP group showed longer operative time than 1-day CP (73.4 vs 54.1 min, The length of hospital stay was shortened in 1-day CP group than in 2-day CP group, while there was no difference in other parameters. Therefore, it is feasible and safe practical policy the use 1-day CP in selected patients who undergo cholecystectomy according to our results.Purpose
Methods
Results
Conclusion
Keywords: Cholecystectomy, Laparoscopic, Critical pathways, Hospital costs
Laparoscopic cholecystectomy is the most effective treatment for patients with symptomatic gallbladder diseases.1–3 Laparoscopic cholecystectomy has been widely used because it is associated with shorter hospital stay, shorter recovery period, lower hospital cost, and postoperative pain reduction. Open cholecystectomy has been limited to acute cholecystitis with complications.4 In recent years, in many hospitals, laparoscopic cholecystectomy has been performed under a systematic treatment algorithm using the critical pathway (CP), which is a series of standardized processes for the diagnosis or treatment of a defined condition based on practice guidelines in order to improve outcomes and reduce costs.3,5–7 Laparoscopic cholecystectomy using CP is based on the concept of rapid recovery after surgery (Enhanced Recovery After Surgery (ERAS)).8 ERAS is a basic concept that helps patients to recover faster after surgery by minimizing the physical effects on the human body and reducing the stress response.9
It has been proved in other studies that it is possible to effectively reduce the hospital stay and the cost of hospitalization when CP is applied. Furthermore, some studies revealed that there was no significant difference in the re-admission rate, visual analogue scale (VAS) pain score, and postoperative complication rate comparing day-surgery and overnight stay surgery in laparoscopic cholecystectomy. However, it was difficult to find studies that directly compare two CPs with different hospital stay period.
The purpose of this study was to evaluate the usefulness of standard guideline for laparoscopic cholecystectomy in terms of length of stay and cost. In this study, we tried to find out whether there is significant difference between 1-day CP (discharge from hospital on postoperative day 1) and 2-day CP (discharge from hospital on postoperative day 2) focused on medical and socioeconomic viewpoints.
This retrospective study was approved by the Institutional Review Boards of the institution (DC16RISI0049). At the department of General Surgery of Daejeon St. Mary’s hospital, two types of CP of laparoscopic cholecystectomy were developed and applied to patients by surgeon’s decision: 1-day CP and 2-day CP. Though there are not different statistically, there was a tendency that patients with multiple comorbidities and history of previous abdominal surgery was preferentially included in the 2-day CP group.
Inclusion and exclusion criteria for CP was summarized in Table 1.
One- and 2-day CPs had the same preoperative and postoperative orders. Lists of IV and PO medications were the same between two CPs.
All patients admitted via outpatient clinic and received elective laparoscopic cholecystectomy. The operation proceeded according to conventional laparoscopic cholecystectomy. The number of laparoscopic ports ranged from single port to 3 ports. The choice of port number determined by various factors such as preference of patient, patient’s age and BMI, history of previous surgery, severity of comorbidities, among others.
Patients visited outpatient department 1 week after the discharge day and complete blood cell count and liver function follow up tests were obtained. After 1 month from the first follow up visit, a second outpatient follow up visit was done. Final postoperative complications data was analyzed including medical records of outpatient clinic.
Numerical Rating Scale (NRS) pain scores were checked during the admission at 8-hour intervals and the number of injection of analgesics was counted.
Total admission cost and actual patient’s expenditures were also analyzed. The actual expenditure of the patient was calculated as the total medical expenses minus the national health insurance payments.
Statistical analysis was done by SPSS version 22 (IBM: Armonk, NY, USA). Heterogeneity of characteristics of two groups was determined by Pearson-x2 test (in case of comparison of proportion) and Student t-test (in case of comparison of continuous variables) with significance set at
From March 2016 to October 2016, among 241 patients who underwent elective laparoscopic cholecystectomy.
With exclusion of 170 patients, finally 71 were enrolled and analyzed. Selected patients were admitted through outpatient department and 1-day CP or 2-day CP was applied, based on patient’s characteristics. Patients were divided into two groups for analysis, 38 patients in the 1-day CP group and 33 patients in the 2-day CP group.
Among 170 excluded patients, 124 were not eligible for CP. Most common reasons for ineligibility were complicated cholecystitis (32 cases) such as gallbladder empyema or perforation. Twenty-seven patients with ASA (American Society of Anesthesiologists) classification of 3 or more were excluded. Nineteen patients had previous upper abdominal operation history and 11 concomitant common bile duct stone. Finally, 35 patients did not agree to be enrolled in CP.
Forty-six patients were dropped out during admission. The most common reason was refusal to be discharged (25 cases) followed by abnormal laboratory results (7 cases), earlier discharge (6 cases), need to get financial support (5 cases), change of operation schedule (1 case), and unexpected concomitant common bile duct stone (1 case). One patient was lost during follow up (Fig. 1).
Pre-operative characteristics of 2-day CP and 1-day CP groups are shown in Table 2. Among the list, there was no statistically significant difference between two groups in age (52 vs 49 years old,
Operative outcomes were summarized in Table 3. Two-day CP group showed longer operative time than 1-day CP group (73.4 vs 54.1 min,
Recently, the application of critical pathway to laparoscopic cholecystectomy has been steadily increasing because it is associated with shorter hospital stay, reduced hospital costs and increased availability of hospital bed capacity.3,10,11
However, there are still some studies reporting unrecognized complications during laparoscopic cholecystectomy, especially in elderly patients with multiple comorbidities.12,13 It is a reasonable concern laparoscopic cholecystectomy using critical pathway may neglect some of the later complications because of forced earlier hospital discharge. Furthermore, complications such as bile duct injury, hemobilia and bowel injury could be life-threatening unless timely detected and properly treated. This is the reason why the critical pathway could not be applied collectively to all patients. In this study, among 241 elective cholecystectomy patients critical pathway was applied to only 117 patients (48.5%). Our critical pathway inclusion rate is lower than other reports because we were more conservative in including patients to critical pathway.
During hospitalization, 46 cases of drop-out were found, however, there was no case of drop-out related to postoperative complications, and none had different treatment or intervention during admission. Most of the drop-out cases were refusal to be discharged complaining postoperative abdominal pain or discomfort. All of them were discharged after one or two more days of admission without different treatment than usual.
There was significant difference in terms of operative time between 1-day and 2-day CP groups. Since the decision to include either in 1-day or 2-day group was taken by the surgeon’s preference or at the patients’ request, selection bias was inevitable. Although not statistically significant, preoperative characteristics (Table 2) showed patients with multiple comorbidities and history of previous abdominal surgery was preferentially included in the 2-day CP group, this factor also may have affected in operative time.
Except for two superficial surgical site infections, there was only one actual postoperative complication in this study. A patient who completed 2-day CP, returned to hospital to outpatient clinic six days after discharge with fever and chilling sensation. Multiple sub centimeter-sized multiple liver abscesses were found on abdominal CT scan. Since this patient had preoperative history of common bile duct stone removal via ERCP, we presumed that subclinical cholangitis existed preoperatively, which developed into multiple small liver abscesses. He was readmitted and properly treated with IV antibiotics and discharged uneventfully on seventh hospital day.
We could not identify statistically significant difference of medical cost between 1-day and 2-day CP groups in this study. However, 1-day CP group showed lower mean and median value of medical cost than 2-day CP group as to both total hospital costs and patients’ expenditures.
Recently, same-day discharge CP after laparoscopic cholecystectomy has been adopted in some hospitals. Henri et al.14 found that careful patient selection, patient education, and experienced surgical team were needed for successful outpatient laparoscopic cholecystectomy utilizing critical pathway. Thomas et al.15 reported that outpatient laparoscopic cholecystectomy with critical pathway was not successful in terms of postoperative recovery in patients older than 50 years, ASA score of 3 or more, and those operated after 1 pm. Discharge plan scheduled in critical pathway was delayed in those patients group.
We did not apply same-day discharge CP of laparoscopic cholecystectomy in our hospital, because we were not sure about the benefits of this kind of patient management strategy and also, there is no firm conclusion whether same-day discharge is safe or not. Beside, our patient population is generally reticent about being discharged on the same day of surgery. Also, in surgical innovation, we thought that conservative step-by-step adaptation is an important policy.
In this study, we did not impose limitation on patients’ age or scheduled operation time for CP enrollment. Actually, oldest patient who underwent laparoscopic cholecystectomy with CP was 81 years old and completed 1-day CP without any complications and there was no case of drop out from CP for afternoon operation schedule. Based on this study, we thought further study about feasibility and safety of outpatient laparoscopic cholecystectomy with CP in selected patients is possible.
In conclusion, though this study has a limitation of being a retrospective review with possible selection bias, it is not only feasible and safe, but also practical the application of 1-day CP for selected patients who undergo laparoscopic cholecystectomy. Our message is 1-day CP application is not inferior to 2-day CP and we hope this study would be helpful for surgeons who wishes to reduce postoperative hospital stay after laparoscopic cholecystectomies.
Nevertheless, larger prospective randomized comparative trials are necessary to confirm our affirmations and draw definitive conclusions.
None.
None.
None.
Table 1 . Inclusion and exclusion criteria for laparoscopic cholecystectomy CP.
Inclusion criteria | Exclusion criteria |
---|---|
Gallbladder stone, gallbladder polyp | Cholecystitis with complications (empyema, perforation) |
Admitted via out-patient department | Accompanied CBD stone |
Agreed with critical pathway | Emergency operation |
ASA classification of 3 or more | |
Open conversion | |
Operative complication; biliary tract injury | |
Refused to be discharged as scheduled | |
Disagreed with critical pathway |
ASA = American Society of Anesthesiologists; CBD = common bile duct..
Table 2 . Patients’ preoperative characteristics comparing 2-day CP and 1-day CP.
All population (N=71) | 2-day CP (N=33) | 1-day CP (N=38) | ||
---|---|---|---|---|
Age (years) | 0.472 | |||
Mean (SD) | 50 (14) | 52 (13) | 49 (15) | |
Median (range) | 48 (24~81) | 50 (31~78) | 46 (24~81) | |
Gender, N (%) | 0.295 | |||
Male | 37 (52.1) | 15 (45.5) | 22 (57.9) | |
Female | 34 (47.9) | 18 (55.5) | 16 (42.1) | |
Comorbidity*, N (%) | 0.127 | |||
Multiple comorbidities | 9 (12.7) | 7 (21.2) | 2 (5.3) | |
One comorbidity | 25 (35.2) | 10 (30.3) | 15 (39.5) | |
None | 37 (52.1) | 16 (48.5) | 21 (55.3) | |
Abdominal surgery, N (%) | 0.373 | |||
Yes | 16 (22.5) | 9 (27.3) | 7 (18.4) | |
No | 55 (77.5) | 24 (72.7) | 31 (81.6) | |
Pre-op ERCP, N (%) | 0.810 | |||
Yes | 10 (14.1) | 5 (15.2) | 5 (13.2) | |
No | 61 (85.9) | 28 (84.8) | 33 (86.8) | |
Diagnosis (pathologic), N (%) | 0.757 | |||
Cholecystitis without stone | 22 (31.0) | 9 (27.3) | 13 (34.2) | |
Cholecystitis with stone | 36 (50.7) | 18 (54.5) | 18 (47.4) | |
Gallbladder polyp | 8 (11.3) | 3 (9.1) | 5 (13.2) | |
Porcelain gallbladder | 1 (1.4) | 1 (3.0) | 0 (0.0) | |
Xanthogranulomatosis | 4 (5.6) | 2 (6.1) | 2 (5.3) |
CP = critical pathway; SD = standard deviation; ERCP = endoscopic retrograde cholangiopancreatography..
Table 3 . Comparison of operative outcomes of 2-day CP and 1-day CP.
All population (N=71) | 2-day CP (N=33) | 1-day CP (N=38) | ||
---|---|---|---|---|
Port number, N (%) | 0.084 | |||
Single port | 31 (43.7) | 18 (54.6) | 13 (34.2) | |
Multiport | 40 (56.3) | 15 (45.4) | 25 (65.8) | |
Operation time (min) | <0.001 | |||
Mean (SD) | 63.1 (23.5) | 73.4 (24.7) | 54.1 (18.4) | |
Median (range) | 59 (25~125) | 70 (40~125) | 53 (25~96) | |
Complication, N (%) | 0.474 | |||
Yes | 3 (4.2) | 2 (6.1) | 1 (2.6) | |
No | 68 (95.8) | 31 (93.9) | 37 (97.4) | |
Pain scale, NRS | 0.052 | |||
Mean (SD) | 2.00 (0.74) | 1.82 (0.64) | 2.16 (0.79) | |
Median (range) | 2 (0~3) | 2 (0~3) | 2 (0~3) | |
Count of analgesics injection, N | 0.754 | |||
Mean (SD) | 0.14 (0.49) | 0.12 (0.42) | 0.16 (0.55) | |
Median (range) | 0 (0~3) | 0 (0~2) | 0 (0~3) | |
Outpatient follow-up laboratory values, Mean (SD) | ||||
WBC (/mm3) | 6617 (1458) | 6494 (1537) | 6724 (1397) | 0.512 |
Hemoglobin (g/dl) | 13.6 (1.2) | 13.5 (1.1) | 13.7 (1.4) | 0.604 |
Total bilirubin (mg/dl) | 0.54 (0.32) | 0.54 (0.41) | 0.54 (0.24) | 0.995 |
AST (IU/L) | 20.0 (9.2) | 18.3 (5.4) | 21.5 (11.4) | 0.137 |
ALT (IU/L) | 24.9 (20.5) | 21.8 (12.4) | 27.7 (25.4) | 0.208 |
Total admission cost, ×104 won | 0.106 | |||
Mean (SD) | 331.51 (34.23) | 347.04 (25.95) | 306.69 (29.80) | |
Median (range) | 328.39 (267.85~398.47) | 343.95 (281.55~398.47) | 296.38 (267.85~385.00) | |
Actual patient’s expenditure, ×104 won | 0.276 | |||
Mean (SD) | 138.03 (24.82) | 147.85 (20.67) | 125.58 (27.97) | |
Median (range) | 137.04 (77.47~179.66) | 150.74 (89.86~189.66) | 122.66 (77.47~185.64) |
Jae Uk Chong, Jung Bum Choi, Mi Ae Seo, Jaekyung Choi, Su Ji Lee, Ja Hye Cheon, and Kyung Sik Kim
J Minim Invasive Surg 2016; 19(2): 57-62Jin Seok Ohn, M.D., Hae Il Jung, M.D., Sang Ho Bae, M.D., Ph.D., Moo-Jun Baek, M.D., Ph.D., Moon Soo Lee, M.D., Ph.D.,
Chang Ho Kim, M.D., Ph.D.
Ji Young Jang, M.D., Sung Hoon Choi, M.D., Ho Kyoung Hwang, M.D., Chang Moo Kang, M.D., Woo Jung Lee, M.D., Ph.D.
J Minim Invasive Surg 2011; 14(2): 51-55